Metformin attenuates cisplatin-induced genotoxicity and apoptosis in rat bone marrow cells

References

• Aleisa, A., et al., 2007. Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 634 (1–2), 93–100.
   PubMed Web of Science ®Google Scholar
• Algire, C., et al., 2012. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prevention Research, 5 (4), 536–543.
   PubMed Web of Science ®Google Scholar
• Asensio-López, M.C., et al., 2011. Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. Free Radical Biology and Medicine, 51 (10), 1861–1871.
   PubMed Web of Science ®Google Scholar
• Attia, S.M., 2010. The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells. Mutagenesis, 25 (3), 281–288.
   PubMed Web of Science ®Google Scholar
• Attia, S.M., 2012. Influence of resveratrol on oxidative damage in genomic DNA and apoptosis induced by cisplatin. Mutation Research, 741 (1–2), 22–31.
   PubMed Web of Science ®Google Scholar
• Attia, S., Helal, G., and Alhaider, A. J. C-b i. 2009. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chemico-Biological Interactions, 180 (2), 296–304.
   PubMed Web of Science ®Google Scholar
• Basu, A., et al., 2017. An oxovanadium (IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage. Drug and Chemical Toxicology, 40 (3), 359–367.
   PubMed Web of Science ®Google Scholar
• Bikas, A., et al., 2016. Metformin attenuates 131I-induced decrease in peripheral blood cells in patients with differentiated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association, 26 (2), 280–286.
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot, D., et al., 2003. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism, 52 (5), 586–589.
   PubMed Web of Science ®Google Scholar
• Brozovic, A., et al., 2010. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Critical Reviews in Toxicology, 40 (4), 347–359.
   PubMed Web of Science ®Google Scholar
• Cavaletti, G., et al., 1994. Protective effects of glutathione on cisplatin neurotoxicity in rats. International Journal of Radiation Oncology, Biology, Physics, 29 (4), 771–776.
   PubMed Web of Science ®Google Scholar
• Chang, J., et al., 2011. Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line. Hearing Research, 282 (1–2), 92–96.
   PubMed Web of Science ®Google Scholar
• Chang, J., et al., 2014. Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line. Journal of the Association for Research in Otolaryngology, 15 (2), 149–158.
   PubMed Web of Science ®Google Scholar
• Cheki, M., et al., 2016. The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 809, 24–32.
   PubMed Web of Science ®Google Scholar
• Das, B., et al., 2008. Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia, 10 (10), 1105.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu, M., et al., 2002. Free radical-induced damage to DNA: mechanisms and measurement. Free Radical Biology and Medicine, 2 (11), 1102–1115.
   Web of Science ®Google Scholar
• Evans, J.M., et al., 2005. Metformin and reduced risk of cancer in diabetic patients. BMJ (Clinical Research ed.), 330 (7503), 1304–1305.
   PubMed Web of Science ®Google Scholar
• Hajihashemi, S., et al., 2013. Free radical scavenging activity of steviol glycosides, steviol glucuronide, hydroxytyrosol, metformin, aspirin and leaf extract of Stevia rebaudiana. Free Radicals and Antioxidants, 3, S34–S41.
   Google Scholar
• Halliwell, B. and Whiteman, M., 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? British Journal of Pharmacology, 142 (2), 231–255.
   PubMed Web of Science ®Google Scholar
• Hou, X., et al., 2010. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochemical and Biophysical Research Communications, 396 (2), 199–205.
   PubMed Web of Science ®Google Scholar
• Kasznicki, J., Sliwinska, A., and Drzewoski, J., 2014. Metformin in cancer prevention and therapy. Annals of Translational Medicine, 2 (6), 57.
   PubMedGoogle Scholar
• Khandelwal, N. and Abraham, S.K., 2014. Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice. Planta Medica, 80 (15), 1278–1283.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2016. Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPKα-regulated autophagy induction. Scientific Reports, 6, 23975.
   PubMed Web of Science ®Google Scholar
• Lin, C.-C., et al., 2013. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription–3 activity independently of the liver kinase B1–AMP-activated protein kinase pathway. American Journal of Respiratory Cell and Molecular Biology, 49 (2), 241–250.
   PubMed Web of Science ®Google Scholar
• Mansour, H.H., El kiki, S.M., and Galal, S.M., 2017. Metformin and low dose radiation modulates cisplatin-induced oxidative injury in rat via PPAR-γ and MAPK pathways. Archives of Biochemistry and Biophysics, 616, 13–19.
   PubMed Web of Science ®Google Scholar
• Mao-Ying, Q.-L., et al., 2014. The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One, 9 (6), e100701.
   PubMed Web of Science ®Google Scholar
• Masuda, H., et al., 1994. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochemical and Biophysical Research Communications, 203 (2), 1175–1180.
   PubMed Web of Science ®Google Scholar
• Mora Lde, O., et al., 2002. The effects of oral glutamine on cisplatin-induced genotoxicity in Wistar rat bone marrow cells. Mutation Research, 518 (1), 65–70.
   PubMed Web of Science ®Google Scholar
• Morales, A.I., et al., 2010. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney International, 77 (10), 861–869.
   PubMed Web of Science ®Google Scholar
• Najafi, M., et al., 2018. Metformin: prevention of genomic instability and cancer: a review. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 827, 1–8.
   PubMed Web of Science ®Google Scholar
• Orio, F., et al., 2007. Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study. European Journal of Endocrinology, 157 (1), 69–73.
   PubMed Web of Science ®Google Scholar
• Pollak, M.J.D., 2017. The effects of metformin on gut microbiota and the immune system as research frontiers. Diabetologia, 60 (9), 1662–1667.
   PubMed Web of Science ®Google Scholar
• Poon, M.K.T., et al., 2003. Metformin protects against carbon tetrachloride hepatotoxicity in mice. Journal of Pharmacological Sciences, 93 (4), 501–504.
   PubMed Web of Science ®Google Scholar
• Qi, X., et al., 2016. Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis. Scientific Reports, 6, 35788.
   PubMed Web of Science ®Google Scholar
• Rabbani, S.I., Devi, K., and Khanam, S., 2010. Role of pioglitazone with metformin or glimepiride on oxidative stress-induced nuclear damage and reproductive toxicity in diabetic rats. The Malaysian Journal of Medical Sciences : MJMS, 17 (1), 3.
   PubMedGoogle Scholar
• Reagan-Shaw, S., Nihal, M., and Ahmad, N., 2008. Dose translation from animal to human studies revisited. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 22 (3), 659–661.
   PubMed Web of Science ®Google Scholar
• Rios, A.O., et al., 2009. Bixin and lycopene modulation of free radical generation induced by cisplatin-DNA interaction. Food Chemistry, 113 (4), 1113–1118.
   Web of Science ®Google Scholar
• Rizos, C.V. and Elisaf, M.S., 2013. Metformin and cancer. European Journal of Pharmacology, 705 (1–3), 96–108.
   PubMed Web of Science ®Google Scholar
• Rjiba-Touati, K., et al., 2012. Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: protective effect of recombinant human erythropoietin. Mutation Research, 747 (2), 202–206.
   PubMed Web of Science ®Google Scholar
• Sahu, B.D., et al., 2013. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation. Experimental and Toxicologic Pathology, 65 (6), 933–940.
   PubMedGoogle Scholar
• Sant'Anna, J.R., et al., 2013. Metformin's performance in in vitro and in vivo genetic toxicology studies. Experimental Biology and Medicine, 238 (7), 803–810.
   Web of Science ®Google Scholar
• Schmid, W.J.M.R., 1975. The micronucleus test. Mutation Research, 31 (1), 9–15.
   PubMed Web of Science ®Google Scholar
• Serpeloni, J.M., et al., 2010. Lutein improves antioxidant defense in vivo and protects against DNA damage and chromosome instability induced by cisplatin. Archives of Toxicology, 84 (10), 811–822.
   PubMed Web of Science ®Google Scholar
• Silva, C.R., et al., 2001. Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. Pharmacological Research, 43 (6), 561–566.
   PubMed Web of Science ®Google Scholar
• Srivastava, A.N., et al., 2010. Cisplatin combination chemotherapy induces oxidative stress in advance non small cell lung cancer patients. Asian Pacific Journal of Cancer Prevention, 11 (2), 465–471.
   PubMedGoogle Scholar
• Suzuki, C.A., et al., 1990. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Toxicology, 64 (2), 113–127.
   PubMed Web of Science ®Google Scholar
• Teixeira, S.F., et al., 2013. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells. Jornal Brasileiro de Pneumologia, 39 (6), 644–649.
   PubMed Web of Science ®Google Scholar
• Ullah, I., et al., 2012. Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neuroscience, 13 (1), 11
   PubMed Web of Science ®Google Scholar
• Viollet, B., et al., 2012. Cellular and molecular mechanisms of metformin: an overview. Clinical Science (London, England : 1979), 122 (6), 253–270.
   PubMed Web of Science ®Google Scholar
• Wang, D. and Wu, X., 2015. In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin. Oncology Letters, 10 (2), 975–981.
   PubMed Web of Science ®Google Scholar
• Wang, Y.-W., et al., 2017. Metformin: a review of its potential indications. Drug Design, Development and Therapy, 11, 2421.
   PubMed Web of Science ®Google Scholar
• Weijl, N.I., et al., 1998. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Annals of Oncology, 9 (12), 1331–1337.
   PubMed Web of Science ®Google Scholar
• Xu, G., et al., 2015. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radical Biology and Medicine, 87, 15–25.
   PubMed Web of Science ®Google Scholar
• Yilmaz, H.R., et al., 2010. Anticlastogenic effect of caffeic acid phenethyl ester on cisplatin-induced chromosome aberrations in rat bone marrow cells. Toxicology and Industrial Health, 26 (1), 33–37.
   PubMed Web of Science ®Google Scholar
• Zhang, Q.S., et al., 2016. Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood, 128 (24), 2774–2784.
   PubMed Web of Science ®Google Scholar
• Zhao, L., et al., 2015. Glutathione selectively modulates the binding of platinum drugs to human copper chaperone Cox17. Biochemical Journal, 472 (2), 217–223.
   PubMed Web of Science ®Google Scholar
• Zhou, W., Kavelaars, A., and Heijnen, C.J., 2016. Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One, 11 (3), e0151890.
   PubMed Web of Science ®Google Scholar
• Zhu, H.-Q., et al., 2016. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo. Oncology Reports, 36 (6), 3488–3496.
   PubMed Web of Science ®Google Scholar